Projects per year
Project Details
Description
GAIN 2 is a phase 2 multicenter, randomized, double-blind, placebo controlled single dosing study of GV150526 in acute stroke within 12 hours of symptom onset The principle aims are to evaluate the safety and tolerability of this dose of GV150526 in acute stroke patients and examine its pharmacoknetics.
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/97 → 9/30/99 |
Funding
- National Center for Research Resources
ASJC Scopus Subject Areas
- Clinical Neurology
- Neurology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Projects
- 0 Finished
-
GENERAL CLINICAL RESEARCH CENTER
Tapley, D. (PI), Morris, T. (PI), Colten, H. (PI) & Al-Awqati, Q. (CoPI)
National Center for Research Resources
12/1/84 → 9/29/06
Project: Research project